For research use only. Not for therapeutic Use.
Tarcocimab（Cat No.:I042115）is an investigational monoclonal antibody designed to target and block the IL-33 (interleukin-33) receptor. IL-33 plays a significant role in the immune system’s inflammatory response and is involved in various allergic and autoimmune conditions. By inhibiting IL-33, Tarcocimab aims to reduce inflammation and prevent immune system dysfunction associated with diseases like asthma and other inflammatory disorders. It is being studied in clinical trials for its potential to treat these conditions, with a focus on improving patient outcomes by targeting the underlying immune mechanisms driving the diseases.
| Catalog Number | I042115 |
| CAS Number | 2408661-40-3 |
| Purity | ≥95% |
